Jeffrey R Deschamps Selected Research

Jeffrey R Deschamps Research Topics

Disease

5	Pain (Aches) 11/2018 - 08/2007
3	Substance-Related Disorders (Drug Abuse) 01/2017 - 08/2014
3	Cocaine-Related Disorders (Cocaine Addiction) 11/2011 - 02/2006
2	Inflammation (Inflammations) 06/2017 - 11/2010
2	Neoplasms (Cancer) 08/2015 - 05/2013
2	Obesity 08/2014 - 08/2012
1	Opioid-Related Disorders (Opiate Addiction) 02/2022
1	Glaucoma 01/2021
1	Macular Edema 01/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019
1	Edema (Dropsy) 11/2018
1	Multiple Sclerosis 06/2017
1	Binge Drinking 11/2015
1	Alcoholism (Alcohol Abuse) 11/2015
1	Nervous System Diseases (Neurological Disorders) 07/2015
1	Parkinson Disease (Parkinson's Disease) 07/2015
1	Restless Legs Syndrome (Restless Legs) 07/2015
1	Schizophrenia (Dementia Praecox) 07/2015
1	Dehydration (Water Stress) 06/2015
1	Psychotic Disorders (Schizoaffective Disorder) 04/2015
1	Tachycardia (Tachyarrhythmias) 04/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 08/2014
1	Panic Disorder (Panic Attack) 08/2014
1	Asthma (Bronchial Asthma) 08/2014
1	Hypothermia 05/2013
1	Weight Loss (Weight Reduction) 08/2012
1	Body Weight (Weight, Body) 08/2012
1	Insulin Resistance 08/2012
1	Communicable Diseases (Infectious Diseases) 11/2011
1	Hypersensitivity (Allergy) 11/2010
1	Chronic Pain 11/2010
1	Pancreatitis 11/2010
1	Chronic Pancreatitis 11/2010
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Intellectual Disability (Idiocy) 06/2009
1	Herpes Simplex 05/2007
1	Ovarian Neoplasms (Ovarian Cancer) 02/2006
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 07/2005
1	Alzheimer Disease (Alzheimer's Disease) 02/2005

Drug/Important Bio-Agent (IBA)

2	Analgesics (Analgesic Drugs)IBA 11/2018 - 11/2010
2	Dopamine D3 ReceptorsIBA 01/2017 - 07/2015
2	Pharmaceutical PreparationsIBA 08/2015 - 11/2011
2	O(2)- (2,4- dinitro- 5- (N- methyl- N- 4- carboxyphenylamino)phenyl 1- N,N- dimethylamino)diazen- 1- ium- 1,2- diolateIBA 08/2015 - 02/2006
2	SaltsIBA 04/2015 - 11/2011
2	Opioid Analgesics (Opioids)IBA 03/2014 - 08/2007
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 02/2005
1	VaccinesIBA 02/2022
1	Heroin (Diamorphine)IBA 02/2022
1	HaptensIBA 02/2022
1	CannabinoidsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	ruboxistaurinIBA 01/2019
1	Mesylates (Mesylate)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 11/2018
1	AutoantigensIBA 06/2017
1	Carbolines (Beta-Carbolines)IBA 11/2015
1	ProdrugsIBA 08/2015
1	Glutathione Transferase (Glutathione S-Transferase)IBA 08/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015
1	Glutathione (Reduced Glutathione)IBA 08/2015
1	EnzymesIBA 08/2015
1	cupric chloride (copper(II) chloride)FDA Link 06/2015
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 06/2015
1	NeuropeptidesIBA 08/2014
1	LeptinIBA 08/2012
1	EndocannabinoidsIBA 08/2012
1	JD5037IBA 08/2012
1	Methylphenidate (Ritalin)FDA LinkGeneric 11/2011
1	Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA 11/2011
1	dibutyldichlorotinIBA 11/2010
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2010
1	Interleukin-6 (Interleukin 6)IBA 11/2010
1	20,21-epoxyresibufogenin-3-formateIBA 11/2010
1	Caspase 9IBA 09/2010
1	CaspasesIBA 09/2010
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2009
1	Guanosine 5'-O-(3-Thiotriphosphate)IBA 08/2007
1	Morphine (MS Contin)FDA LinkGeneric 08/2007
1	bicyclo(3.1.0)hexaneIBA 05/2007
1	Thymidine KinaseIBA 05/2007
1	ThymidineIBA 05/2007
1	Cocaine (Cocaine HCl)IBA 01/2007
1	octaneIBA 01/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2006
1	Cisplatin (Platino)FDA LinkGeneric 02/2006
1	Sulfhydryl Compounds (Thiols)IBA 07/2005
1	PhysostigmineIBA 02/2005
1	CarbamatesIBA 02/2005
1	Amyloidogenic ProteinsIBA 02/2005

Therapy/Procedure

1	Quantum Dots (Quantum Dot) 06/2017
1	Self Administration (Administration, Self) 11/2015
1	Analgesia 05/2013
1	Drug Therapy (Chemotherapy) 11/2011
1	Therapeutics 11/2010